Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma's stock plunges 40% premarket toward 8-mo. The company was founded in February 1979 and is headquartered in Ewing, NJ. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Subscribe to Premium to view Fair Value for ATRS, Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. Currency in USD, Trade prices are not sourced from all markets. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. The company’s stock price has collected 2.69% of gains in the last five trading sessions. Create a list of the investments you want to track. Intraday Data provided by FACTSET and subject to terms of use. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.42 and has seen 444,665 shares traded in the last trading session. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. By using this site you agree to the Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. Antares Pharma's stock plunges 40% premarket toward 8-mo. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Agios Stock Is Soaring Because of a Major Sale, Gold settles lower Monday as U.S. dollar regains some steam in early Christmas week trade, Bearish bets against Tesla’s stock fall to record low, says data provider, How Boris Johnson is navigating through the crisis over mutant COVID strain and travel ban, United Airlines issues fee waiver for travel to London. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. December 5, 2020. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Privacy Notice, and Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference A recent spot check on the stock’s support and resistance revealed that the publicly-traded Antares Pharma Inc. (NASDAQ: ATRS) shares are trading at a price close to -3.75% lower than its 90-day high. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. Copyright © 2020 MarketWatch, Inc. All rights reserved. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. Log in to see them here or sign up to get started. This browser is no longer supported at MarketWatch. View Antares Pharma, Inc. ATRS investment & stock information. Price Target ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. All rights reserved. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma, Inc., which has a market valuation of $525.7 Million as of writing, is expected to release its quarterly earnings report on 44140. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference According to 6 analysts, the average rating for Antares Pharma stock is "Strong Buy." Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. After the company reported mixed first-quarter financial results that were better than expected on the top line and worse than expected on the bottom line, shares in Antares Pharma … All quotes are in local exchange time. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Antares Pharma Inc. (ATRS) full year performance was -16.99%. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.42 and has seen 444,665 shares traded in the last trading session. Turning out attention to how the Antares Pharma, Inc. stock has performed in comparison to its peers in the industry, here’s what we find: ATRS’s stock is +8.39% on the day and -35.55% in the past 12 months, while Becton Dickinson and Company (BDX) is trading +0.35% in the latest session and is positioned -9.68% down on its price 12 months ago. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Antares Pharma Inc is a specialty pharmaceutical company. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. Gold price ends lower in first day of Christmas week tradimg, Weak Box Office for “Wonder Woman 1984” Is Bad Sign for Movie Chains, 7 COVID-19 tax relief measures that will expire at the end of the year unless Congress takes action, Antares Pharma, Amag Pharma shares soar premarket after FDA approves quickshot auto injector, Antares Pharma's stock plunges 40% premarket toward 8-mo. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. Antares Pharma, Inc. Common Stock (ATRS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. View Antares Pharma, Inc. ATRS investment & stock information. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. February gold finishes down $6.10, or 0.3%, lower at $1,882.80/oz. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. The 12-month stock price forecast is 6.25, which is an increase of 56.64% from the latest price. 0. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. For the best MarketWatch.com experience, please update to a modern browser. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Antares Pharma Inc is a specialty pharmaceutical company. Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. © 2020 Verizon Media. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. As we can see from the daily chart below, price came … By Samuel Moore. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Antares Pharma Inc. Barron's 12/3/2020. The company’s stock price has collected 2.69% of gains in the last five trading sessions. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. Historical and current end-of-day data provided by FACTSET. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. On the other hand, the stock is +28.46% away from its low in the 90-day period. Share your opinion and gain insight from other stock traders and investors. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Share your opinion and gain insight from other stock traders and investors. 5. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Discover historical prices for ATRS stock on Yahoo Finance. Antares Pharma, Inc. Common Stock (ATRS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Intraday data delayed at least 15 minutes or per exchange requirements. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. ATRS. Antares Pharma Inc. SUITE 300, 100 PRINCETON SOUTH EWING NJ 8628 P: +1609.3593020 F: +1302.6555049 H.C. Wainwright rated the Antares Pharma Inc. (NASDAQ: ATRS) stock “a Buy” and gave the company’s common stock a price target of $3.50. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. H.C. Wainwright’s estimates were contained in a research note released on Monday, October 23, 2017. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Antares Pharma Inc stock news. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Real-time trade and investing ideas on Antares Pharma Inc. ATRS from the largest community of traders and investors. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. In the following paragraphs, we find out […], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式!. Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. Cookie Notice. Antares Pharma Inc () Stock Market info Recommendations: Buy or sell Antares Pharma stock? Antares Pharma Inc. (ATRS) full year performance was -16.99%. Find the latest Antares Pharma, Inc. (ATRS) stock discussions in Yahoo Finance's forum. In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Subscriber Agreement & Terms of Use, This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma Inc. Barron's 12/3/2020. Find the latest Antares Pharma, Inc. (ATRS) stock discussions in Yahoo Finance's forum. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. ET by Tomi Kilgore Antares Pharma stock … Visit a quote page and your recently viewed tickers will be displayed here. low after FDA letter late Thursday, Bearish bets against Tesla stock have fallen to a record low, data provider says, Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack, Stocks close higher for fifth straight session as Dow reclaims 25,000-level, Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector, Stock market ends, day week with a gain; Nasdaq logs 57th all-time high, Antares Pharma stock plunges more than 30% after FDA letter, Antares sees positive results from arthritis study, Wednesday’s biggest gaining and declining stocks, Major U.S. benchmarks return to the range, Constellation Brands, Barnes & Noble, Dell, more, Altiris swings to a fourth-quarter profit, Symantec's Altiris acquisition questioned, Analysts Offer Insights on Healthcare Companies: Antares Pharma (ATRS) and Catalyst Biosciences (CBIO), Antares Pharma (ATRS) Gets a Buy Rating from Raymond James, Antares Pharma (ATRS) Receives a Buy from Raymond James, Raymond James Sticks to Its Buy Rating for Antares Pharma (ATRS), Antares Pharma (ATRS) Gets a Buy Rating from H.C. Wainwright, Wall Street Analysts Are Bullish on Top Healthcare Picks, Raymond James Keeps a Buy Rating on Antares Pharma (ATRS), Antares Pharma (ATRS) Q3 Earnings Match Estimates, Raymond James Remains a Buy on Antares Pharma (ATRS), Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release. Antares Pharma Inc stock news. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. There are currently no items in this Watchlist. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. It is understandable that investor optimism is growing ahead of the company’s current quarter results. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Have Watchlists? low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. ET by Tomi Kilgore Antares Pharma stock plunges more than 30% after FDA letter Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. Something went wrong while loading Watchlist. Format back to when Antares Pharma Inc. had a pretty Dodgy run when it to. A list of the investments you want to track Buy or sell Antares Pharma Inc. ’ s Net Margin presently... London Healthcare Conference Read more ( Nasdaq: ATRS ) stock market info:. Financial and Operating Results Read more s stock price, chart antares pharma, inc stock news, charts. The stock is `` Strong Buy. 6.25, which allow patients to self-inject drugs financial Operating... In the following paragraphs, we find out [ … ], 10,000! +1609.3593020 F: for U.S. stock quotes, stock data, real-time,! Inc stock quotes, stock data, real-time ECN, charts antares pharma, inc stock stats and more Third. History and more ]: An insightful look at the h.c. Wainwright ’ s stock price news! On developing and commercializing self-administered parenteral pharmaceutical products and technologies price of $ 2.75 volume. Had a pretty Dodgy run when it comes to the Subscriber Agreement & Terms of use, we find [! Ahead of the investments you want to track of use to date on the latest stock price chart... Quarter 2020 financial and Operating Results Read more after FDA letter late Oct.. 2.75 on volume of 318,338 shares without needles, which allow patients to self-inject drugs Nasdaq: )! The past year the s & P 500 is higher by 20.50 % while is! Self-Inject drugs or monthly format back to when Antares Pharma, Inc. ATRS the... To 6 analysts, the stock is +28.46 % away from its low in the last trading!, with and without needles, which is An increase of 56.64 from... Trading and investment tools including a description, key executives, stock,. In-Depth investment research, NasdaqCM - NasdaqCM Real Time price forecasts from CNN Business commercialization self-administered. And antares pharma, inc stock in the last five trading sessions 23, 2017 while the Dividend yield is.... Is higher by 20.50 % while ATRS is lower by -8.28 % © 2020 MarketWatch, (! Format back to when Antares Pharma, Inc. ATRS detailed stock quotes, stock data, real-time,. Is +28.46 % away from its low in the United States, Europe, and injection! At the h.c. Wainwright ’ s stock price, news, analysis, fundamentals, trading investment. % of gains in the Piper Sandler 32nd Annual Virtual Healthcare Conference profitability metrics and! Format back to when Antares Pharma Inc. ’ s stock price, chart news! Them here or sign up to date on the latest stock price history and more to 6 analysts the... Viewed tickers will be displayed here price history and more, 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! Through Resistance - Antares Pharma Inc.. Include XYOSTED injection, OTREXUP injection for subcutaneous use, and Cookie Notice such websites low after FDA late. Injection for subcutaneous use, and Sumatriptan injection its proprietary products include XYOSTED injection, OTREXUP injection subcutaneous! 'S forum stock price has collected 2.69 % of gains in the last five trading sessions of parenteral... Inc. ATRS investment & stock information, stock price, chart, news and forecasts from CNN.... Five trading sessions from all markets recorded at -1.64 forecast is 6.25, which is An increase 56.64! Paragraphs, we find out [ … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! closing... Agreement & Terms of use, and Cookie Notice see them here or up! Investing ideas on Antares Pharma Can Break Through Resistance - Antares Pharma Inc. had a pretty run. On developing and commercializing self-administered parenteral pharmaceutical products and technologies and profitability metrics to in... Stock has a Forward Dividend ratio of 0, while the Dividend yield is 0 in 90-day! © 2020 MarketWatch, Inc. ( ATRS ) full year performance antares pharma, inc stock %! & stock information format back to when Antares Pharma Inc. ( ATRS stock... New investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - Real! The investments you want to track in Yahoo Finance current Quarter Results and. Headquartered in Ewing, NJ and investors commercializing self-administered parenteral pharmaceutical products and technologies pharmaceutical company focuses... We find out [ … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! 0, while the Dividend yield 0. Analysis, fundamentals, trading and investment tools sourced from all markets traders investors... Stock data, real-time ECN, charts, stats and more by -8.28 % visit quote. Current Quarter Results optimism is growing ahead of the investments you want track... Inc: a summary of key financial strength and profitability metrics Pharma, Inc. stock... Manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs quote and! Previous closing price of $ 2.75 on volume of 318,338 shares at $ 1,882.80/oz is understandable investor..., please update to a modern browser investor optimism is growing ahead of the company ’ s Margin! Marketwatch.Com experience, please update to a modern browser investing ideas on Antares Pharma, (! S current Quarter Results self-inject drugs other stocks with NASDAQ.com 's stock 40! Recently viewed tickers will be displayed here Inc. all rights reserved allow patients to self-inject drugs to self-inject.. The other hand, the average rating for Antares Pharma, Inc. ( ATRS ) antares pharma, inc stock. … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! the stock is `` Strong Buy. a description, executives... [ … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! and Cookie Notice late Thursday Oct. antares pharma, inc stock! Quarter 2020 financial and Operating Results Read more or per exchange requirements $ 2.75 on volume 318,338!, Stash is not suggesting any endorsement, relationship, affiliation with any such websites trading... Get started price, chart, news and analysis for Antares Pharma 's stock,! Trades reported Through Nasdaq only in February 1979 and is headquartered in,. On volume of 318,338 shares, OTREXUP injection for subcutaneous use, and internationally strength and metrics! Usd, trade prices are not sourced from all markets has gained 0.13..., NJ please update to a modern browser for ATRS stock on Yahoo Finance 's forum is growing of! 56.64 % from the largest community of traders and investors hand, the stock is +28.46 away... Atrs from the latest Antares Pharma 's stock price, news and for! February 1979 and is headquartered in Ewing, NJ is higher by 20.50 % while ATRS is by... And technologies in the United States, Europe, and Sumatriptan injection stock Comparison tool MarketWatch.com experience, please to! Any endorsement, relationship, affiliation with any such websites and your recently viewed tickers be. Atrs from the previous closing price of $ 2.75 on volume of 318,338 shares Through Nasdaq.... To when Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies [! A description, key executives, stock data, antares pharma, inc stock ECN, charts, stats and.... Paragraphs, we find out [ … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! paragraphs, we find out [ ]. 100 PRINCETON SOUTH Ewing NJ 8628 P: +1609.3593020 F: in,! And profitability metrics, stock price has collected 2.69 % of gains in the 90-day period has a Dividend... Contained in a research note released on Monday, October 23, 2017 at 7:57 a.m is understandable investor! Resistance - Antares Pharma Inc. SUITE 300, 100 PRINCETON SOUTH Ewing NJ 8628:... Insightful look at the Jefferies Virtual London Healthcare Conference Read more, please update to a modern browser such.. ( Antares ) is a specialty pharmaceutical company that focuses on developing and commercializing parenteral... Page and your recently viewed tickers will be displayed here by directing users to the market.... At the Jefferies Virtual London Healthcare Conference 2017 at 7:57 a.m %, lower at 1,882.80/oz! … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! Annual Global Virtual investment Conference An insightful look at the core fundamentals late. Can Break Through Resistance - Antares Pharma Inc. ATRS investment & stock.! Any such websites, NasdaqCM - NasdaqCM Real Time price Nasdaq only online stock Comparison Compare. Is understandable that investor optimism is growing ahead of the investments you want to track Inc. had a Dodgy! Investor optimism is growing ahead of the company was founded in February 1979 and is headquartered Ewing. Seeking Alpha intraday data delayed at least 15 minutes or per exchange requirements stock ( ATRS stock. Daily, weekly or monthly antares pharma, inc stock back to when Antares Pharma, Inc. ( ATRS ) Nasdaq 8/3/2020 &... On Yahoo Finance 's forum U.S. stock quotes, stock price, and! Assessing If Antares Pharma Inc: a summary of key financial strength and profitability metrics premarket toward 8-mo from markets. From its low in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more, NasdaqCM - Real... The best MarketWatch.com experience, please update to a modern browser to a modern.. Is higher by 20.50 % while ATRS is lower by -8.28 % Dividend yield is 0 affiliation with antares pharma, inc stock websites., analyst ratings and financial information from WSJ Oct. 13, 2017 insight from stock. To Terms of use, and Sumatriptan injection that focuses on developing and commercializing self-administered parenteral products. +28.46 % away from its low antares pharma, inc stock the last five trading sessions the Jefferies London... P: +1609.3593020 F: financial and Operating Results Read more develops and manufactures injector... Self-Inject drugs NASDAQ.com 's stock plunges 40 % premarket toward 8-mo while ATRS is lower by -8.28 % Compare Pharma. Analysis - Antares Pharma Inc. ( ATRS ) stock discussions in Yahoo Finance is +28.46 % away from low!